Advanced search allows to you precisely focus your query. Search within a content type, and even narrow to one or more resources. You can also find results for. Resumo. PEREZ DELGADO, Yanet; MURADAS AUGIER, Marilét e SOTOLONGO MOLINA, Yolanda. Anticoagulant and antiplatelet agents: considerations in the. Manejo de medicamentos anticoagulantes y antiplaquetarios en pacientes sometidos a cirugías electivas oftalmológicas. Christine A Kiire,1.
|Published (Last):||4 August 2005|
|PDF File Size:||12.28 Mb|
|ePub File Size:||20.10 Mb|
|Price:||Free* [*Free Regsitration Required]|
J Am Soc Echocardiogr. Procoagulant activity after off-pump antocoagulantes operations: Anticoagulants; antiplatelet; surgical patient. Mayo Clinic Health Letter. O uso de HNF em baixas doses 5. Living with prosthetic heart valves.
Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: Antithrombotic therapy for VTE disease: Management of acute coronary syndromes in developing countries: Does simplicity compromise accuracy in ACS risk prediction? A comparison of rate control and rhythm control in patients with atrial fibrillation. Optimal INR for prevention of stroke and death in atrial anticoagluantes No subgrupo de 3.
Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteers. The role of the dermatologist in detecting elder abuse and neglect. Heparina de baixo peso molecular 7.
The management of patients with hip fractures who are taking Clopidogrel. Factors at admission associated with bleeding risk in medical patients: Atrial fibrillation as an independent risk factor for stroke: American College of Chest Physicians. J Am Coll Cardiol. Thromboembolism and bleeding after mitral valve replacement with j valves: Paddock M, et al.
Rev cuba anestesiol reanim [online]. Aspirin and other antiplatelet drugs in the prevention of venous thromboembolism. Como citar este artigo.
Prevention of VTE in orthopedic surgery patients: Risk factors for intracranial hemorrhage in outpatients taking warfarin. Escrito por el personal de Mayo Clinic.
Manejo de medicamentos anticoagulantes y antiplaquetarios en by Bruno Braga on Prezi
Addition of clopidogrel to aspirin in 45, patients with acute myocardial infarction: Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. Prasugrel versus clopidogrel in patients with acute coronary syndromes. Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: Low-molecular-weight heparin and mortality in acutely ill medical patients.
Davi G, Patrono C. Low-dose aspirin for preventing recurrent venous thromboembolism. Approach to the patient who antiplaquetafios or has abnormal coagulation.
Development of a recombinant antithrombin variant as a potent antidote to fondaparinux and other heparin derivatives. Goldman L, et al. Eur J Clin Pharmacol. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. Randomised comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement. Platelet activation and atherothrombosis. Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin anticoaulantes in non-ST-segment elevation acute coronary syndromes: Mortality rates in patients with ST-elevation vs.
There was a problem providing the content you requested
Role of orally available antagonists of factor Xa in the treatment and prevention of thromboembolic disease: Bivalirudin for patients with acute coronary syndromes. Antithrombotic therapy in patients with saphenous and internal mammary artery bypass grafts. Influence of antiplatelet therapy on cerebral micro-emboli after carotid endarterectomy using postoperative transcranial Doppler monitoring.